Cardiac performance is limited by oxygen delivery to the mitochondria in the crystalloid-perfused working heart
Related Experiment Video
Updated: Feb 19, 2026

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
Published on: May 12, 2019
Sarah Kuzmiak-Glancy1,2, Raúl Covian2, Armel N Femnou1,2
1Department of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
Insights
Crystalloid-perfused hearts show oxygen-limited cardiac function. Adding oxygen-carrying perfluorocarbons (PFCs) improves myocardial oxygen delivery, mitochondrial function, and cardiac performance, creating a more physiological state.
Area of Science:
- Cardiovascular Physiology
- Biochemistry
- Biomedical Engineering
Background:
- Crystalloid-perfused working heart models are crucial for studying cardiac function and pharmacology.
- Oxygen delivery limitations in these models can affect myocardial function, particularly concerning myoglobin oxygenation and oxidative phosphorylation (OxPhos).
- The impact of reduced myoglobin oxygen saturation on OxPhos remains unclear due to myoglobin's lower oxygen affinity compared to cytochrome c oxidase (COX).
Purpose of the Study:
- To develop an affordable perfluorocarbon (PFC) emulsion for enhanced perfusate oxygen carrying capacity.
- To investigate the effects of PFC supplementation on myocardial oxygenation, mitochondrial redox state, and cardiac function in a left ventricular working heart model.
- To determine if oxygen delivery limitations impact oxidative phosphorylation and cardiac performance in crystalloid-perfused hearts.
Main Methods:
- Laboratory synthesis of an affordable perfluorocarbon (PFC) emulsion.
- Utilizing a left ventricular working heart model perfused with either Krebs-Henseleit (KH) buffer or KH supplemented with PFC.
- Monitoring cardiac function, metabolic rate, myoglobin oxygenation, and mitochondrial cytochrome redox state using transmural illumination optical absorbance spectroscopy.
Main Results:
- PFC supplementation increased perfusate oxygen carrying capacity by 3.6-fold.
- In KH-perfused hearts, myoglobin was deoxygenated and mitochondrial cytochromes were highly reduced, indicating cytoplasmic and OxPhos hypoxia.
- PFC perfusate significantly increased aortic output, oxygen consumption, myoglobin oxygenation, and oxidized mitochondrial cytochromes, improving cardiac work over a wider range of perfusate oxygen levels.
Conclusions:
- The commonly used crystalloid-perfused working heart model is limited by oxygen delivery to mitochondria, impacting oxidative phosphorylation and cardiac work.
- Supplementation with oxygen-carrying PFCs effectively reverses mitochondrial hypoxia by enhancing myocardial oxygen delivery.
- PFCs improve cardiac performance and establish a more physiological mitochondrial redox state, highlighting the critical role of oxygen delivery in modulating cardiac function.
Abstract:
The left ventricular working, crystalloid-perfused heart is used extensively to evaluate basic cardiac function, pathophysiology, and pharmacology. Crystalloid-perfused hearts may be limited by oxygen delivery, as adding oxygen carriers increases myoglobin oxygenation and improves myocardial function. However, whether decreased myoglobin oxygen saturation impacts oxidative phosphorylation (OxPhos) is unresolved, since myoglobin has a much lower affinity for oxygen than cytochrome c oxidase (COX). In the present study, a laboratory-based synthesis of an affordable perfluorocarbon (PFC) emulsion was developed to increase perfusate oxygen carrying capacity without impeding optical absorbance assessments. In left ventricular working hearts, along with conventional measurements of cardiac function and metabolic rate, myoglobin oxygenation and cytochrome redox state were monitored using a novel transmural illumination approach. Hearts were perfused with Krebs-Henseleit (KH) or KH supplemented with PFC, increasing perfusate oxygen carrying capacity by 3.6-fold. In KH-perfused hearts, myoglobin was deoxygenated, consistent with cytoplasmic hypoxia, and the mitochondrial cytochromes, including COX, exhibited a high reduction state, consistent with OxPhos hypoxia. PFC perfusate increased aortic output from 76 ± 6 to 142 ± 4 ml/min and increased oxygen consumption while also increasing myoglobin oxygenation and oxidizing the mitochondrial cytochromes. These results are consistent with limited delivery of oxygen to OxPhos resulting in an adapted lower cardiac performance with KH. Consistent with this, PFCs increased myocardial oxygenation, and cardiac work was higher over a wider range of perfusate Po2. In summary, heart mitochondria are limited by oxygen delivery with KH; supplementation of KH with PFC reverses mitochondrial hypoxia and improves cardiac performance, creating a more physiological tissue oxygen delivery. NEW & NOTEWORTHY Optical absorbance spectroscopy of intrinsic chromophores reveals that the commonly used crystalloid-perfused working heart is oxygen limited for oxidative phosphorylation and associated cardiac work. Oxygen-carrying perfluorocarbons increase myocardial oxygen delivery and improve cardiac function, providing a more physiological mitochondrial redox state and emphasizing cardiac work is modulated by myocardial oxygen delivery.
Related Concept Videos
Pathophysiology of Cardiac Performance
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Cardiac Output I:Effect of Heart Rate on Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...

